IP Library Granted Patent US 7,504,556
Granted Patent B2
US 7,504,556 · App. 10/703,906 · Granted Mar 17, 2009

Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,556
App. No.
10/703,906
Granted
Mar 17, 2009
Kind
B2
Abstract

Methods for engineering transgenic organisms that synthesize polyhydroxyalkanoates (PHAs) containing 3-hydroxyhexanoate as comonomer have been developed. These processes are based on genetically engineered bacteria such as Escherichia coli or in plant crops as production systems which include PHA biosynthetic genes from PHA producers. In a preferred embodiment of the method, additional genes are introduced in wild type or transgenic polyhydroxybutyrate (PHB) producers, thereby creating new strains that synthesize 3HH monomers which are incorporated into PHAs. The 3HH monomer preferably is derived in microbial systems using butanol or butyrate as feedstocks, which are precursors of 3-hydroxyhexanoyl-CoA. Pathways for in vivo production of butyrol-CoA specifically encompassing butyryl-CoA dehydrogenase activity are provided.

Claims (22)

1. A method for the biological production of polyhydroxyalkanoates containing 3-hydroxyhexanoate in plants, comprising synthesizing the polyhydroxyalkanoate in plants expressing an enzyme selected from the group consisting of PHB polymerase, PHA polymerase, and β-ketoacyl-CoA reductase, wherein the plants are genetically engineered by integration into the chromosome of one or more genes encoding one or more enzymes forming a fatty acid oxidation complex, wherein the fatty acid oxidation complex comprises enzymes selected from the group consisting of enzymes epimerizing S-3 hydroxyhexanoyl CoA and enzymes reducing 3-ketohexanoyl CoA.

2. The method of claim 1 wherein the plant is selected from the group consisting of oil crop plants and starch accumulating plants.

3. The method of claim 2 wherein the plant is selected from the group consisting of Brassica, sunflower, soybean, corn, safflower, flax, palm, coconut, potato, tapioca, cassava, alfalfa, grass, and tobacco.

4. The method of claim 1 wherein the plant is genetically engineered to express or overexpress a PHA polymerase incorporating C6 substrates.

5. The method of claim 4 wherein the enzyme is derived from Aeromonas caviae, Comamonas testosteroni, Thiocapsia pfenigii, Chromatium vinosum, Bacillus cereus, Nocardia carolina, Nocardia salmonicolor, Rhodococcus ruber, Rhodococcus rhodocrous , and Rhodospirilum rubrum.

6. The method of claim 1 wherein the plant is genetically engineered to redirect metabolites to production of 3-hydroxyhexanoyl-CoA.

7. The method of claim 6 wherein the plant is genetically engineered using a D-specific enoyl-CoA hydratase gene.

8. The method of claim 7 wherein the hydratase gene is isolated from a bacteria selected from the group consisting of R. eutropha, Klebsiella aerogenes, P. putida , and Aeromonas caviae.

9. The method of claim 6 wherein the plant is genetically engineered using a butyrate fermentation pathway.

10. The method of claim 9 wherein the butyrate fermentation pathway is from Clostridium acetobutylicium or Thermoanaerobacterium thermosaccharolyticum.

11. The method of claim 9 wherein the plant is genetically engineered to convert butyrate to butyryl CoA or butyryl CoA to crotonyl CoA.

12. The method of claim 9 wherein the plant is genetically engineered to express a broad range reductase that is active on C6 substrates.

13. The method of claim 9 wherein the plant is genetically engineered to express a polymerase that accepts 3-hydroxyhexanoyl CoA.

14. The method of claim 9 wherein the plant is genetically engineered to express a thiolase accepting acetoacetyl CoA.

15. The method of claim 9 wherein the plant is genetically engineered to express an enzyme selected from the group consisting of thiolases specific for 3-ketohexanoyl CoA, reductase active on 3-ketohexanoyl CoA, PHA polymerase that accepts 3-hydroxybutyryl CoA and 3-hydroxyhexanoyl CoA.

16. The method of claim 6 wherein the plant is genetically engineered to integrate one or more nucleic acids encoding fatty acid biosynthetic enzymes derived from E. coli.

17. The method of claim 16 wherein the fatty acid biosynthetic enzymes are enzymes converting acyl ACP to acyl CoA.

18. The method of claim 17 where the enzymes are selected from the group consisting of ACP-CoA transacylase, acyl ACP thioesterase, and acyl CoA synthase.

19. The method of claim 18 wherein the enzymes are acyl ACP thioesterase and acyl CoA synthase.

20. The method of claim 1 wherein the fatty acid oxidation complex comprises enzymes epimerizing S-3 hydroxyhexanoyl CoA and enzymes reducing 3-ketohexanoyl CoA.

21. The method of claim 20 wherein the enzymes are derived from Nocardia salmonicolor.

22. The method of claim 20 wherein the enzymes for epimerization are derived from Pseudomonas putida FaoAB complex.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: CJ RESEARCH CENTER LLC
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 042522/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2017
From: METABOLIX, INC.
To: CJ RESEARCH CENTER LLC
Reel/Frame 041234/0890 →
ADDRESS CHANGE Recorded May 2, 2016
From: METABOLIX, INC.
To: METABOLIX, INC.
Reel/Frame 038665/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2005
From: MADISON, LARA; HUISMAN, GJALT W.; PEOPLES, OLIVER P.
To: METABOLIX, INC.
Reel/Frame 016552/0360 →